Mangoceuticals (MGRX) Non Operating Interest Expenses (2025)
Mangoceuticals' (MGRX) quarterly Non Operating Interest Expenses came in at $19663.0 in Q4 2025, down 74.08% quarter-over-quarter from $75850.0 in Q3 2025.
Powered by 
Analysis
Mangoceuticals (MGRX) Non Operating Interest Expenses (2025) Analysis & Trends
Mangoceuticals has disclosed Non Operating Interest Expenses across 1 years of filings, most recently posting $19663.0 for Q4 2025.
- In Q4 2025, Non Operating Interest Expenses changed N/A year-over-year to $19663.0; the TTM figure through Dec 2025 stood at $103513.0 (changed N/A YoY), while the FY2025 annual figure was $103513.0, up 655.57% from the prior year.
- Non Operating Interest Expenses came in at $19663.0 for Q4 2025 at Mangoceuticals, down from $75850.0 in the prior quarter.
- In the past five years, Non Operating Interest Expenses ranged from a high of $75850.0 in Q3 2025 to a low of -$13700.0 in Q1 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non Operating Interest Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Hinge Health | 7.41 Bn | 7.03 Bn | 183.95 Mn | - |
| 2 | Hims & Hers Health | 6.47 Bn | 5.63 Bn | 480.80 Mn | - |
| 3 | Ethos Technologies | 2.54 Bn | 2.37 Bn | 185.54 Mn | 616,000.00 |
| 4 | Omada Health | 1.38 Bn | 1.16 Bn | 63.79 Mn | 14,000.00 |
| 5 | Teladoc Health | 1.14 Bn | 366.41 Mn | 416.09 Mn | 5.11 Mn |
| 6 | Talkspace | 870.58 Mn | 779.48 Mn | 24.80 Mn | - |
| 7 | Akso Health | 259.44 Mn | 259.25 Mn | - | - |
| 8 | LifeMD | 147.29 Mn | 147.29 Mn | - | - |
| 9 | eHealth | 31.71 Mn | -69.34 Mn | - | 4.05 Mn |
| 10 | Mangoceuticals | 7.39 Mn | 7.14 Mn | 44,215.00 | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 19,663.00 |
| Sep 30, 2025 | 75,850.00 |
| Jun 30, 2025 | 21,700.00 |
| Mar 31, 2025 | -13,700.00 |